Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Himanshu A. Gupte"'
Autor:
Gauri Mandal, Srinath Satyanarayana, Amol R. Dongre, Thulasingam Mahalakshmy, Himanshu A. Gupte
Publikováno v:
Population Medicine, Vol 3, Iss June, Pp 1-10 (2021)
Introduction India has 267 million adult tobacco users, the majority of whom are part of the economically productive workforce. Workplaces are ideal settings to influence tobacco use behavior. A 6-month tobacco cessation program was implemented in fi
Externí odkaz:
https://doaj.org/article/b03d8f4227274fa9ba8f2b899b9255d9
Autor:
Sitara L Mahtani, Kasisomayajula Viswanath, Himanshu A Gupte, Gauri Mandal, Dinesh Jagiasi, Ratandeep Chawla, Marina D'Costa, Ziming Xuan, Sara Minsky, Shoba Ramanadhan
Publikováno v:
JMIR Research Protocols, Vol 13, p e57236 (2024)
BackgroundAbout 1.35 million deaths annually are attributed to tobacco use in India. The main challenge, given the magnitude of tobacco use and limited resources, is delivering cessation support at scale, low cost, and through a coordinated cross-sys
Externí odkaz:
https://doaj.org/article/7656d8b79d10418aaaceb6e2b6fafb53
Publikováno v:
National Journal of Community Medicine, Vol 11, Iss 02 (2020)
Background: Private non-allopathic practitioners are often the first point of medical care for low-income populations in India, and likely encounter a sizeable number of tobacco-users. While there is evidence that physicians’ advice for tobacco ces
Externí odkaz:
https://doaj.org/article/eccb7e130b98459daa934e9b6f07cd07
Autor:
Benjamin Asamoah, Appiah-Korang Labi, Himanshu A. Gupte, Hayk Davtyan, Georgette Marfo Peprah, Forster Adu-Gyan, Divya Nair, Karlos Muradyan, Nasreen S. Jessani, Paul Sekyere-Nyantakyi
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 24; Pages: 16556
Management of urinary tract infections is challenged by increasing antimicrobial resistance (AMR) worldwide. In this study, we describe the trends in antimicrobial resistance of uropathogens isolated from the largest private sector laboratory in Ghan
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0203262 (2018)
BACKGROUND:Provision of Anti-Retroviral Therapy (ART) and Opioid Substitution Therapy (OST) are important components of the targeted intervention (TI) programme for people who inject drugs (PWID). Homeless HIV positive PWIDs in Delhi is a key populat
Externí odkaz:
https://doaj.org/article/29241e76501a453f904c2567b30cff9a
Autor:
Tanu Anand, Jugal Kishore, Petros Isaakidis, Himanshu A Gupte, Gurmeet Kaur, Sneha Kumari, Diwakar Jha, Shekhar Grover
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0202256 (2018)
BACKGROUND:Evidence supports the integration of prevention and management for tuberculosis (TB) with non-communicable diseases (NCDs). Bi-directional screening for TB and diabetes mellitus (DM) is already implemented in India, a country with a dual b
Externí odkaz:
https://doaj.org/article/21c5823ee0cc4dd183bddb9eed45fb67
Publikováno v:
Substance Abuse and Rehabilitation.
Himanshu A Gupte,1 Nilesh Chatterjee,1 Gauri Mandal2 1Narotam Sekhsaria Foundation, Mumbai, Maharashtra, India; 2Salaam Bombay Foundation, Mumbai, Maharashtra, IndiaCorrespondence: Nilesh Chatterjee, Narotam Sekhsaria Foundation, First Floor, Nirmal
Autor:
Thulasingam Mahalakshmy, Himanshu A Gupte, Srinath Satyanarayana, Amol R Dongre, Gauri Mandal
Publikováno v:
Population Medicine, Vol 3, Iss June, Pp 1-10 (2021)
Introduction India has 267 million adult tobacco users, the majority of whom are part of the economically productive workforce. Workplaces are ideal settings to influence tobacco use behavior. A 6-month tobacco cessation program was implemented in fi
Publikováno v:
Workplace Health Saf
Background: Tobacco use is projected to cause more than 8 million deaths annually worldwide by 2030 and is currently linked to 1 million annual deaths in India. Very few workplaces provide tobacco cessation as a part of occupational health in India.
Publikováno v:
Tobacco Prevention & Cessation
Tobacco Prevention and Cessation, Vol 6, Iss September, Pp 1-5 (2020)
Tobacco Prevention and Cessation, Vol 6, Iss September, Pp 1-5 (2020)
Introduction Tobacco use is detrimental at any time. However, it is proving to be more dangerous during the COVID-19 pandemic. Tobacco use may increase the risk of being infected, increases the chances of complications, and also increases the probabi